In accordance with Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, for the Quarter ended on September 30, 2025, based on the certificate received from Beetal Financial & Computer Services (RTA) dated 07/10/2025, which is enclosed, Titan Biotech has forwarded the same.
The above information is a part of company’s filings submitted to BSE.